Oved Amitay is the Chief Executive Officer at Solve M.E. He has dedicated most of his professional career to the development of life-changing therapeutic options for people affected by rare genetic diseases.
Throughout his career, Oved had extensive engagements with healthcare systems and patient advocacy organizations around the world, forging collaborations to address the needs of people affected by rare genetic diseases. Oved is frequently invited to speak on topics related to orphan drugs, the development and commercialization of therapies for patients with rare diseases.
Oved is a registered pharmacist, trained at the School of Pharmacy, Hebrew University in Jerusalem, and holds an M.Sc. in Pharmacology from Northeastern University in Boston. He has a certificate from the program for Critical and Creative Thinking at the University of Massachusetts Boston. Oved also has more than twenty years of leadership experience as an officer in the Israeli Defense Forces.
Oved served as Chief Business Officer at CENTOGENE (NASDAQ: CNTG), a global leader in the diagnostics of rare hereditary disorders where his overall responsibility for the company´s programs with the biotechnology and pharmaceutical industry included enhancing existing partnerships and establishing new collaborations to facilitate drug development and improve treatment outcomes.
Oved joined CENTOGENE from Arrett Neuroscience, where he held the position of President and Chief Operating Officer, having led the company’s strategy for developing therapies for Rett syndrome. Prior to that, he served as Vice President, Head of Commercial at Alnylam Pharmaceuticals (NASDAQ: ALNY), where he played a lead role in the organization’s transition from a technology-platform focused company to a patient-centric drug development and pre-launch enterprise. Oved had a long tenure at Genzyme Corporation (now Sanofi Genzyme) as Vice President, Strategic Development, responsible for program management, business development, market assessment, and business planning for the rare genetic diseases franchise. Prior to that position, he was General Manager of the Gaucher Disease and MPS Portfolios, where he was responsible for the flagship product Cerezyme®, leading it to peak sales of over $1.2 billion. He also oversaw the development of the drug Eliglustat, which was approved by the FDA and EMA for the treatment of Gaucher Disease. Oved joined Genzyme in 1998 and held positions of increasing responsibility in regulatory affairs, marketing, and business development in Europe and the Middle East. Prior to joining Genzyme, he was a staff pharmacologist at Peptor Ltd. (Israel) and Cambridge NeuroScience, Inc. (MA, USA), where he was involved in early-stage drug development programs.
He is also a Founding Advisor of Splisense Therapeutics, Israel.
Jessie Brown-Clark is the Advocacy and Engagement Manager at Solve M.E. She has a bachelor’s degree in psychology from Pepperdine University where she also studied non-profit management. Before joining Solve M.E., she served as an educational advocate for students with disabilities and the coordinator for a children’s literacy organization.
Patti Johns Eisenberg is the Major Gifts Officer at Solve M.E. Patti comes from the world of conservation and the arts. She has worked for African Parks, Yosemite Conservancy, and Pasadena Playhouse. She is proud of the art of fundraising and passionate about philanthropy, learns from others, and always listens to donors. Philanthropy is an opportunity to put one’s values into action. Patti likes to tap into generosity by building communities based on trust and joy. She has three grown daughters and a small dog named Alexander Hamilton.
Ray Johnson is the Development Coordinator at Solve M.E. He has a bachelor’s degree in Communication Studies from the University of Texas at Austin. Before joining Solve M.E., he worked in the homelessness sector, helping various nonprofit organizations rework their operations and fundraising processes. He is a lifelong advocate and is passionate about using data and research to empower disenfranchised groups.
Joe Komsky is the Director of Development at Solve M.E. Joe has worked in non-profit for thirty years, the last twenty raising money for medical research, health advocacy, and patient care. During that time, Joe has collaborated with volunteers, colleagues, scientists, and doctors to raise over $50 million to improve healthcare. His fundraising philosophy is not about pressure or salesmanship, but rather, “let’s talk about how you want to change the world and how we can work together to make that happen.”
Joe is excited to join Solve M.E. at a time of such potential growth for the organization. A passionate fundraiser and builder of high-performing teams, he hopes to use those skills to help patients and their families. Joe’s other passion is his family and the Los Angeles Dodgers, though not always in that order. He lives in Manhattan Beach with his wife, teenage daughter, and two rescue dogs.
Karman Kregloe is the Communications and Media Relations Manager at Solve M.E. She has a master’s degree in American Studies from the University of New Mexico and a bachelor’s degree in English from Virginia Tech. Before joining Solve M.E, she was the editor-in-chief of an MTV-owned LGBTQ news site.
Leslie E. Phillips, PhD is the Consulting Director of Product Management and Operation at Solve M.E. An epidemiologist specializing in clinical epidemiology, research study design and analysis, and best practices for data collection, Leslie is accomplished in helping organizations navigate complex epidemiologic questions, providing insight and support to better understanding the ME/CFS landscape. Leslie holds a Master’s Degree in Public Health from Harvard University and a Doctorate in Epidemiology from the University of Washington. She has served in a variety of analytic and leadership capacities in research and public health and, in addition to epidemiology, has expertise in survey research, health equity, population health, and Lean Startup methodologies.
At Solve, Leslie is focused on “getting under the hood” to identify data insights that can be translated into actionable next steps. As a Seattle resident through many a grey, wet winter, Leslie has developed an excessive addiction to coffee and an impressive collection of GORE-TEX.
Allison Ramiller is the Director of Research Programs at Solve M.E. Allison obtained a bachelor’s degree in psychology with minors in neuroscience and sociology at the University of California, Davis and a master’s degree in Public Health at the University of California, Berkeley. Allison has always been passionate about working for the public interest and with disenfranchised populations. Prior to joining Solve M.E., she served as Special Assistant in the Washington office of the Brennan Center for Justice, a think tank and advocacy organization that works to strengthen our systems of democracy and justice. She previously worked for the Oxnard Police Department’s Crime Analysis Unit in Southern California and interned with Innocence Matters, an organization that works to exonerate individuals who were wrongfully convicted.
Deborah Saady is the Accounting and Operations Manager of Solve M.E. Deborah brings more than twenty-five years of accounting, finance, and administration experience across government, for-profit and not-for-profit sectors. After completing her studies at the University of Maryland, she pursued dual careers in accounting and choreography in her native Washington, DC until relocating to Los Angeles in 2010. Deborah spends her free time baking, taking dance classes, taking classes toward her MBA, and competitive ballroom dancing. She is proud to be a member of this dedicated staff.
Elle Seibert is the Registry Data Manager at Solve M.E. Of East Coast origins, Elle moved across the country in pursuit of her studies in Neuroscience. During her time at the University of Southern California, Elle developed an indefatigable love for the interplay between science, philosophy, and the arts. To this end, she enjoys bringing together different kinds of minds to think deeply about the world’s most pressing social-scientific issues.
Emily Taylor is the Director of Advocacy and Community Relations for Solve M.E. She brings to the organization over fifteen years of policy, organization, and advocacy experience in both the non-profit and government sectors. With five years’ experience on Capitol Hill, Emily contributes a keen understanding of both state and federal policy processes while cultivating strong grassroots organization and patient representation.
Prior to joining the Solve M.E., Emily served as the director of policy and advocacy for an award-winning autism organization. There she spearheaded major overhauls in disability, early intervention, and education policies. She is also a veteran of several successful electoral campaigns, where she trained others in effective social media and online organization. She received a B.A. with honors in politics and international relations from Scripps College in Claremont and earned her M.A. in American politics from Claremont Graduate University. Emily draws inspiration from her mother who has battled ME/CFS as well as chronic autoimmune and thyroid conditions since 1999.
Ani Vahradyan is the Public Relations and Social Media Coordinator at Solve M.E. She has a master’s degree in Public Relations from Boston University and a bachelor’s degree in media studies from the University of California, Berkeley, where she also studied journalism. Prior to joining Solve M.E., Ani held various writing and editorial positions at on-campus publications. She brings with her an innate passion for storytelling.
Sadie Whittaker, PhD is the Chief Scientific Officer of Solve M.E. Sadie has over 14 years of experience in the biotech industry, in clinical development for biologic medicines, and in strategic leadership roles for advocacy, policy, communication, and external engagement. Sadie brings to the organization a deep understanding of the scientific discovery, drug development, and drug commercialization processes, as well as extensive experience in engaging members of the healthcare community.
A firm believer in the power of collaboration to tackle difficult public health problems, Sadie has spearheaded and led a number of highly successful public: private partnerships and multi-sector coalitions that have resulted in meaningful change.
Sadie’s passion lies in using her education and expertise to make a difference in the lives of patients, and she is keen to apply her skill set to advancing the discovery of treatments for patients living ME/CFS.
She received her PhD in molecular biology at University of Birmingham, UK, and her BSc in Biochemistry from University of Leeds, UK.